Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | General Mills Inc | 33 |
| 2 | Ascendis Pharma AS | 27 |
| 3 | Firmenich Inc | 9 |
| 4 | Lineage Cell Therapeutics Inc | 9 |
| 5 | Aventis Pharmaceuticals Inc | 6 |
| 6 | Valagro SpA | 5 |
| 7 | Boston Scientific Corp | 4 |
| 8 | Avenir Wellness Solutions of California Inc | 3 |
| 9 | Boston Scientific Scimed Inc | 3 |
| 10 | Henry H Ottens Manufacturing Co Inc | 3 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 151 |
| 2 | A61P | Therapeutic activity (drug indications) | 95 |
| 3 | A23L | Foods and beverages (general) | 47 |
| 4 | A23P | 35 | |
| 5 | Y02A | Climate change adaptation | 30 |
| 6 | A61Q | Cosmetics, personal care | 29 |
| 7 | A61M | Devices for introducing media into the body | 25 |
| 8 | B01J | Chemical/physical processes (e.g. catalysts) | 23 |
| 9 | A21D | 19 | |
| 10 | A23C | 19 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Biochemical effects in animals | 1 |
| 2 | Coenzyme Q10 studies and effects | 1 |
| 3 | Radiation Effects and Dosimetry | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Ebbe Søndergaard | Rigshospitalet | 6 |
| 2 | Henrik Dam | Rigshospitalet | 5 |
| 3 | G. Hjort | 4 | |
| 4 | H Dyggve | Rigshospitalet | 4 |
| 5 | H. K. Hanel | 4 |
| 6 | P. R. Purser | 4 | |
| 7 | D.H. Marrian | University of Cambridge | 3 |
| 8 | E Quagliariello | 3 | |
| 9 | L Peguiron | 3 | |
| 10 | Sigismund Neukomm | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Menadione-induced Reactive Oxygen Species Generation via Redox Cycling Promotes Apoptosis of Murine Pancreatic Acinar Cells | 2006 | 381 | Pancreatitis Pathology and Treatment |
| Quinone Oxidoreductases and Vitamin K Metabolism | 2008 | 92 | Alcoholism and Thiamine Deficiency |
| The Effect of Large Doses of Synkavit in the Newborn | 1956 | 75 | Urological Disorders and Treatments |
| Comparison of the Action of Vitamin K1, Menadione and Synkavit administered Intravenously to Vitamin K Deficient Chicks. | 1953 | 43 | Vitamin K Research Studies |
| Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancy | 2005 | 42 | Neuroendocrine Tumor Research Advances |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of Synkavit?
Which organizations hold the most patents for Synkavit?
What research areas are associated with Synkavit in the patent literature?
What scientific studies have examined Synkavit or related menadione compounds?
How has patent activity for Synkavit evolved in recent years?